Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis

被引:109
作者
Liu, Dan [1 ,2 ,3 ]
Su, Longxiang [4 ,5 ]
Han, Gencheng [6 ]
Yan, Peng [1 ]
Xie, Lixin [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Pulm & Crit Care Med, Beijing 100853, Peoples R China
[2] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China
[3] Tianjin Med Univ, Dept Resp Med, Gen Hosp, Tianjin 300070, Peoples R China
[4] Peking Union Med Coll Hosp, Dept Crit Care Med, Peking Union Med Coll, Beijing 100005, Peoples R China
[5] Chinese Acad Med Sci, Beijing 100005, Peoples R China
[6] Inst Basic Med Sci, Immunol Lab, Beijing 100850, Peoples R China
关键词
CRITICALLY-ILL PATIENTS; C-REACTIVE PROTEIN; SEPTIC SHOCK; EMERGENCY-DEPARTMENT; HOSPITAL MORTALITY; DISEASE SEVERITY; DIAGNOSTIC-VALUE; PREDICTION; ADMISSION; PRESEPSIN;
D O I
10.1371/journal.pone.0129450
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Procalcitonin (PCT) has been widely investigated for its prognostic value in septic patients. However, studies have produced conflicting results. The purpose of the present meta-analysis is to explore the diagnostic accuracy of a single PCT concentration and PCT non-clearance in predicting all-cause sepsis mortality. We searched PubMed, Embase, Web of Knowledge and the Cochrane Library. Articles written in English were included. A 2 x 2 contingency table was constructed based on all-cause mortality and PCT level or PCT nonclearance in septic patients. Two authors independently evaluated study eligibility and extracted data. The diagnostic value of PCT in predicting prognosis was determined using a bivariate meta-analysis model. We used the Q-test and I-2 index to test heterogeneity. Twenty-three studies with 3,994 patients were included. An elevated PCT level was associated with a higher risk of death. The pooled relative risk (RR) was 2.60 (95% confidence interval (CI), 2.05-3.30) using a random-effects model (I-2 = 63.5%). The overall area under the summary receiver operator characteristic (SROC) curve was 0.77 (95% CI, 0.73-0.80), with a sensitivity and specificity of 0.76 (95% CI, 0.67-0.82) and 0.64 (95% CI, 0.52-0.74), respectively. There was significant evidence of heterogeneity for the PCT testing time (P = 0.020). Initial PCT values were of limited prognostic value in patients with sepsis. PCT non-clearance was a prognostic factor of death in patients with sepsis. The pooled RR was 3.05 (95% CI, 2.35-3.95) using a fixed-effects model (I2 = 37.9%). The overall area under the SROC curve was 0.79 (95% CI, 0.75-0.83), with a sensitivity and specificity of 0.72 (95% CI, 0.58-0.82) and 0.77 (95% CI, 0.55-0.90), respectively. Elevated PCT concentrations and PCT non-clearance are strongly associated with all-cause mortality in septic patients. Further studies are needed to define the optimal cut-off point and the optimal definition of PCT non-clearance for accurate risk assessment.
引用
收藏
页数:15
相关论文
共 52 条
[1]   Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin:: correlation with mortality and postoperative complications [J].
Adamik, B ;
Kübler-Kielb, J ;
Golebiowska, B ;
Gamian, A ;
Kübler, A .
INTENSIVE CARE MEDICINE, 2000, 26 (09) :1259-1267
[2]   Performance evaluation of MR-proadrenomedullin and other scoring systems in severe sepsis with pneumonia [J].
Akpinar, Serdar ;
Rollas, Kazim ;
Alagoz, Ali ;
Segmen, Fatih ;
Sipit, Tugrul .
JOURNAL OF THORACIC DISEASE, 2014, 6 (07) :921-929
[3]  
[Anonymous], 2014, ENCYCL EARLY CHILD D
[4]   Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment [J].
Behnes, Michael ;
Bertsch, Thomas ;
Lepiorz, Dominic ;
Lang, Siegfried ;
Trinkmann, Frederik ;
Brueckmann, Martina ;
Borggrefe, Martin ;
Hoffmann, Ursula .
CRITICAL CARE, 2014, 18 (05)
[5]   Prognostic value of troponins in sepsis: a meta-analysis [J].
Bessiere, Francis ;
Khenifer, Safia ;
Dubourg, Julie ;
Durieu, Isabelle ;
Lega, Jean-Christophe .
INTENSIVE CARE MEDICINE, 2013, 39 (07) :1181-1189
[6]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[7]   Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock [J].
Clec'h, C ;
Fosse, JP ;
Karoubi, P ;
Vincent, F ;
Chouahi, I ;
Hamza, L ;
Cupa, M ;
Cohen, Y .
CRITICAL CARE MEDICINE, 2006, 34 (01) :102-107
[8]   EasyMA: A program for the meta-analysis of clinical trials [J].
Cucherat, M ;
Boissel, JP ;
Leizorovicz, A ;
Haugh, MC .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 1997, 53 (03) :187-190
[9]   "Merinoff Symposium 2010: Sepsis"-Speaking with One Voice [J].
Czura, Christopher J. .
MOLECULAR MEDICINE, 2011, 17 (1-2) :2-3
[10]   Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis [J].
Dahaba, A. A. ;
Hagara, B. ;
Fall, A. ;
Rehak, P. H. ;
List, W. F. ;
Metzler, H. .
BRITISH JOURNAL OF ANAESTHESIA, 2006, 97 (04) :503-508